Pediatric HIV infection: neurologic and neuropsychologic findings

Area of Science:

• Pediatric Neurology
• Neurovirology
• Childhood Infectious Diseases

Background:

• Neurologic and neuropsychologic findings are crucial early prognostic indicators for symptomatic HIV disease in children.
• Common presentations in infants include encephalopathy, loss of motor milestones, and corticospinal tract abnormalities.

Purpose of the Study:

• To highlight the significance of early identification of infants at high risk for central nervous system (CNS) disease progression.
• To emphasize the need for effective treatments to mitigate HIV's impact on the developing brain.
• To identify measures for monitoring treatment responses in HIV-affected children.

Main Methods:

• Review of neurologic and neuropsychologic findings in infants, children, and adolescents with HIV.
• Analysis of risk factors for severe CNS disease progression, including basal ganglia calcification and CD4+ counts.
• Discussion of diagnostic and monitoring strategies for HIV-related CNS disease.

Main Results:

• Infants with basal ganglia calcification and low or declining CD4+ counts are at high risk for severe CNS disease.
• Older children and adolescents with HIV may show subtle neurologic dysfunction late in the illness, including attentional difficulties and tremors.
• Severe neurologic manifestations in infancy may be linked to in utero HIV infection or infant vulnerability during rapid brain growth.

Conclusions:

• Early identification of high-risk infants is critical for timely intervention against HIV-related CNS disease.
• Neuropsychologic, neuroimaging, and laboratory measures are needed to monitor treatment efficacy.
• Understanding HIV's impact on the developing brain is essential for improving outcomes in affected children.